RITSUKO KOMAKI to Cyclooxygenase Inhibitors
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Cyclooxygenase Inhibitors.
Connection Strength
0.283
-
Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer. Semin Oncol. 2004 Feb; 31(1 Suppl 1):47-53.
Score: 0.216
-
Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Am J Clin Oncol. 2003 Aug; 26(4):S85-91.
Score: 0.052
-
A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Clin Cancer Res. 2005 May 01; 11(9):3342-8.
Score: 0.015